Data / Form D filings / CEPHEID
CEPHEID: Form D filing
CEPHEID, a biotechnology company in Sunnyvale, CA, filed a Form D with the SEC in 2013. The latest, on January 28, 2013, reports $5.2 million sold of a $5.2 million offering to 2 investors.
Find out what CEPHEID does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 904 CARIBBEAN DRIVE, Sunnyvale, CA, 94089
- Phone
- (408) 541-4191
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- California
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1037760
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 28, 2013 | New notice | $5,200,000 | $5,200,000 | $0 | 2 | Dec 20, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David H. Persing | Executive Officer, Director | |
| Thomas L. Gutshall | Director | |
| Kerry H. Flom | Executive Officer | |
| Cristina H. Kepner | Director | |
| Andrew l. Miller | Executive Officer | |
| Thomas D. Brown | Director | |
| Robert J. Easton | Director | |
| John l. Bishop | Executive Officer, Director | |
| Humberto H. Reyes | Executive Officer | |
| Hollings C. Renton | Director | |
| Dean H. Morton | Director | |
| Joseph H. Smith | Executive Officer | |
| Glenn D. Steele | Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
Every Form D from the week of Jan 28, 2013 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CEPHEID reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.